Stock Trends
The 2026 Base Finder
Good morning,
It’s time for the fourth annual Base Finder edition of Stock Trends.
Before we get into the charts, a few notes for first-time readers.
We’re looking for big bases here. That means at least several months, but in most cases a year or longer of accumulation with a clear horizontal resistance level.
Big bases are all about potential. Not every base is going to work but the hope is for significant upside once the stock breaks out of its base.
Just because it’s in this report, doesn’t mean it is a buy right now. With bases, we’re looking to either buy a breakout or be there before the breakout if the stock is showing the right combination of short-term momentum and relative strength. Several stocks here are already on our Blue Chip Hot List and all are future candidates. But I’m not officially endorsing it until it goes on the Blue Chip Hot List.
Finally, this year’s stocks are organized into several groups, namely:
Blue skies potential
Bottoming bases
Stocks that have already broken out
BRB (Be right back) or stocks that are retesting the top of a big base
Let’s get into it!
Note that all charts shown are with weekly candlesticks and relative to the S&P 500 in the bottom panel. All prices are as of this weekend’s close (December 19) so we aren’t looking at incomplete candles, but I’ve reviewed all the holdings and notated any material stock price moves over the past two days.
Blue skies potential
These are the most ideal base setups, all things equal. A base below all-time highs indicates a breakout would put every current shareholder in the green and leaves no overhead supply as potential resistance.
A: Agilent Technologies
A false breakout four weeks ago (and three down weeks since) means Agilent Technologies is just on the watch list for now.
ABT: Abbott Laboratories
Also heading the wrong direction short-term, watch support at $120.
AFL: Aflac
Get ready to see a lot of insurance charts, including some that have already broken out. That’s the expectation for Aflac.
AMGN: Amgen
18-month base within a decade-long uptrend.








